• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Elizabeth B. Claus, MD, PhD


  • Arvold ND, Tanguturi SK, Aizer AA, Wen PY, Reardon DA, Lee EQ, Nayak L, Christianson LW, Horvath MC, Dunn IF, Golby AJ, Johnson MD, Claus EB, Chiocca EA, Ligon KL, Alexander BM.
    Hypofractionated Versus Standard Radiation Therapy With or Without Temozolomide for Older Glioblastoma Patients.
    Int J Radiat Oncol Biol Phys. 2015 Apr 1.
  • Ramkissoon SH, Bi WL, Schumacher SE, Ramkissoon LA, Haidar S, Knoff D, Dubuc A, Brown L, Burns M, Cryan JB, Abedalthagafi M, Kang YJ, Schultz N, Reardon DA, Lee EQ, Rinne ML, Norden AD, Nayak L, Ruland S, Doherty LM, LaFrankie DC, Horvath M, Aizer AA, Russo A, Arvold ND, Claus EB, Al-Mefty O, Johnson MD, Golby AJ, Dunn IF, Chiocca EA, Trippa L, Santagata S, Folkerth RD, Kantoff P, Rollins BJ, Lindeman NI, Wen PY, Ligon AH, Beroukhim R, Alexander BM, Ligon KL.
    Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.
    Neuro Oncology. 2015 Mar 9.
  • Jalali A, Amirian ES, Bainbridge MN, Armstrong GN, Liu Y, Tsavachidis S, Jhangiani SN, Plon SE, Lau CC, Claus EB, Barnholtz-Sloan JS, Il'yasova D, Schildkraut J, Ali-Osman F, Sadetzki S, Johansen C, Houlston RS, Jenkins RB, Lachance D, Olson SH, Bernstein JL, Merrell RT, Wrensch MR, Davis FG, Lai R, Shete S, Aldape K, Amos CI, Muzny DM, Gibbs RA, Melin BS, Bondy ML.
    Targeted sequencing in chromosome 17q linkage region identifies familial glioma candidates in the Gliogene Consortium.
    Sci Rep. 2015;5:8278.
  • Claus EB, Walsh KM, Wiencke JK, Molinaro AM, Wiemels JL, Schildkraut JM, Bondy ML, Berger M, Jenkins R, Wrensch M.
    Survival and low-grade glioma: the emergence of genetic information.
    Neurosurg Focus. 2015 Jan;38(1):E6.
  • Aizer AA, Arvold ND, Catalano P, Claus EB, Golby AJ, Johnson MD, Al-Mefty O, Wen PY, Reardon DA, Lee EQ, Nayak L, Rinne ML, Beroukhim R, Weiss SE, Ramkissoon SH, Abedalthagafi M, Santagata S, Dunn IF, Alexander BM.
    Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.
    Neuro Oncology. 2014 Jun 2.
  • Andersson U, Wibom C, Cederquist K, Aradottir S, Borg A, Armstrong GN, Shete S, Lau CC, Bainbridge MN, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Houlston RS, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Lachance DH, Wrensch M, Davis FG, Merrell R, Johansen C, Sadetzki S, , Bondy ML, Melin BS.
    Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.
    Neuro Oncology. 2014 Apr 9.
  • Schildkraut JM, Calvocoressi L, Wang F, Wrensch M, Bondy ML, Wiemels JL, Claus EB.
    Endogenous and exogenous hormone exposure and the risk of meningioma in men.
    J Neurosurg. 2014 Apr;120(4):820-6.
  • Sadetzki S, Bruchim R, Oberman B, Armstrong GN, Lau CC, Claus EB, Barnholtz-Sloan JS, Il'yasova D, Schildkraut J, Johansen C, Houlston RS, Shete S, Amos CI, Bernstein JL, Olson SH, Jenkins RB, Lachance D, Vick NA, Merrell R, Wrensch M, Davis FG, McCarthy BJ, Lai R, Melin BS, Bondy ML, .
    Description of selected characteristics of familial glioma patients - Results from the Gliogene Consortium.
    Eur J Cancer. 2013 Apr;49(6):1335-45.
  • Claus EB, Wiemels J, Wrensch M.
    Dental x-rays and risk of meningioma: response to Drs. Calnon, Jorgensen, and White.
    Cancer. 2013 Jan 15;119(2):465-6.
  • Wiemels JL, Bracci PM, Wrensch M, Schildkraut J, Bondy M, Pfefferle J, Zhou M, Sison J, Calvocoressi L, Claus EB.
    Assessment of autoantibodies to meningioma in a population-based study.
    Am J Epidemiol. 2013 Jan 1;177(1):75-83.
  • Claus EB, Calvocoressi L, Bondy ML, Wrensch M, Wiemels JL, Schildkraut JM.
    Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females.
    J Neurosurg. 2012 Oct 26.
  • Sun X, Vengoechea J, Elston R, Chen Y, Amos CI, Armstrong G, Bernstein JL, Claus EB, Davis F, Houlston RS, Il'yasova D, Jenkins RB, Johansen C, Lai R, Lau C, Liu Y, McCarthy BJ, Olson SH, Sadetzki S, Schildkraut JM, Shete SS, Yu R, Vick NA, Merrell R, Wrensch MR, Yang P, Melin B, Bondy ML, Barnholtz-Sloan JS.
    A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma.
    Cancer Epidemiol Biomarkers Prev. 2012 Sep 7.
  • Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M.
    Dental x-rays and risk of meningioma.
    Cancer. 2012 Sep 15;118(18):4530-7.
  • Liu Y, Melin BS, Rajaraman P, Wang Z, Linet M, Shete S, Amos CI, Lau CC, Scheurer ME, Tsavachidis S, Armstrong GN, Houlston RS, Hosking FJ, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, LaChance D, Vick NA, Wrensch M, Davis F, McCarthy BJ, Andersson U, Thompson PA, Chanock S, , Bondy ML.
    Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma.
    Hum Genet. 2012 Sep;131(9):1507-17.
  • Dyer MA, Kelly PJ, Chen YH, Pinnell NE, Claus EB, Lee EQ, Weiss SE, Arvold ND, Lin NU, Alexander BM.
    Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
    Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e479-86.
  • Claus EB, Walsh KM, Calvocoressi L, Bondy ML, Schildkraut JM, Wrensch M, Wiemels JL.
    Cigarette smoking and risk of meningioma: the effect of gender.
    Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):943-50.
  • Cahill KS, Chi JH, Day AL, Claus EB.
    Trends in survival after surgery for breast cancer metastatic to the brain and spinal column in medicare patients: a population-based analysis.
    Neurosurgery. 2011 Mar;68(3):705-13; discussion 713.
  • Wiemels J, Wrensch M, Claus EB.
    Epidemiology and etiology of meningioma.
    J. Neurooncol. 2010 Sep;99(3):307-14.
  • Robertson LB, Armstrong GN, Olver BD, Lloyd AL, Shete S, Lau C, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Yang P, Rynerason AL, Wrensch M, McCoy L, Wienkce JK, McCarthy B, Davis F, Vick NA, Johansen C, BĂždtcher H, Sadetzki S, Bruchim RB, Yechezkel GH, Andersson U, Melin BS, Bondy ML, Houlston RS.
    Survey of familial glioma and role of germline p16 ( INK4A ) /p14 ( ARF ) and p53 mutation.
    Fam Cancer. 2010 Sep;9(3):413-21.
  • Norden AD, Drappatz J, Wen PY, Claus EB.
    Survival among patients with primary central nervous system lymphoma, 1973-2004.
    J. Neurooncol. 2010 Jun 17.
  • Claus EB, Abdel-Wahab M, Burger PC, Engelhard HH, Ellison DW, Gaiano N, Gutmann DH, Heck DA, Holland EC, Jallo GI, Kruchko C, Kun LE, Maria BL, Rumboldt Z, Seminara D, Spinella GM, Stophel L, Wechsler-Reya R, Wrensch M, Gilbertson RJ.
    Defining future directions in spinal cord tumor research: proceedings from the National Institutes of Health workshop.
    J Neurosurg Spine. 2010 Feb;12(2):117-21.
  • Claus EB, Park PJ, Carroll R, Chan J, Black PM.
    Specific genes expressed in association with progesterone receptors in meningioma.
    Cancer Res. 2008 Jan 1;68(1):314-22.
  • Calvocoressi L, Sun A, Kasl SV, Claus EB, Jones BA.
    Mammography screening of women in their 40s: impact of changes in screening guidelines.
    Cancer. 2008 Feb 1;112(3):473-80.
  • Malmer B, Adatto P, Armstrong G, Barnholtz-Sloan J, Bernstein JL, Claus E, Davis F, Houlston R, Il'yasova D, Jenkins R, Johansen C, Lai R, Lau C, McCarthy B, Nielsen H, Olson SH, Sadetzki S, Shete S, Wiklund F, Wrensch M, Yang P, Bondy M.
    GLIOGENE an International Consortium to Understand Familial Glioma.
    Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1730-4. Review.
  • Claus EB, Black PM, Bondy ML, Calvocoressi L, Schildkraut JM, Wiemels JL, Wrensch M.
    Exogenous hormone use and meningioma risk: what do we tell our patients?.
    Cancer. 2007 Aug 1;110(3):471-6. Review.
  • Claus EB, Black PM.
    Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001.
    Cancer. 2006 Mar 15;106(6):1358-63.
  • Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM.
    Epidemiology of intracranial meningioma.
    Neurosurgery. 2005 Dec;57(6):1088-95; discussion 1088-.
  • Calvocoressi L, Stolar M, Kasl SV, Claus EB, Jones BA.
    Applying Recursive Partitioning to a Prospective Study of Factors Associated with Adherence to Mammography Screening Guidelines.
    Am J Epidemiol. 2005 Dec 15;162(12):1215-24.
  • Claus EB, Petruzella S, Matloff E, Carter D.
    Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ.
    JAMA. 2005 Feb 23;293(8):964-9.
  • Claus EB, Horlacher A, Hsu L, Schwartz RB, Dello-Iacono D, Talos F, Jolesz FA, Black PM.
    Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance.
    Cancer. 2005 Mar 15;103(6):1227-33.
  • Calvocoressi L, Kasl SV, Lee CH, Stolar M, Claus EB, Jones BA.
    A prospective study of perceived susceptibility to breast cancer and nonadherence to mammography screening guidelines in African American and White women ages 40 to 79 years.
    Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2096-105.
  • Claus EB, Stowe M, Carter D, Holford T.
    The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry.
    Breast. 2003 Dec;12(6):451-6.
  • Claus EB.
    Risk models used to counsel women for breast and ovarian cancer: a guide for clinicians.
    Fam Cancer. 2001;1(3-4):197-206.
  • Claus EB, Stowe M, Carter D.
    Oral contraceptives and the risk of ductal breast carcinoma in situ.
    Breast Cancer Res Treat. 2003 Sep;81(2):129-36.
  • Claus EB, Stowe M, Carter D.
    Family history of breast and ovarian cancer and the risk of breast carcinoma in situ.
    Breast Cancer Res Treat. 2003 Mar;78(1):7-15.
  • DiGiovanna MP, Chu P, Davison TL, Howe CL, Carter D, Claus EB, Stern DF.
    Active signaling by HER-2/neu in a subpopulation of HER-2/neu-overexpressing ductal carcinoma in situ: clinicopathological correlates.
    Cancer Res. 2002 Nov 15;62(22):6667-73.
  • Claus EB, Stowe M, Carter D.
    Breast carcinoma in situ: risk factors and screening patterns.
    J Natl Cancer Inst. 2001 Dec 5;93(23):1811-7.
  • Claus EB, Chu P, Howe CL, Davison TL, Stern DF, Carter D, DiGiovanna MP.
    Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptors.
    Exp Mol Pathol. 2001 Jun;70(3):303-16.
  • Claus EB.
    Risk models in genetic epidemiology.
    Stat Methods Med Res. 2000 Dec;9(6):589-601.
  • Chiang VL, Claus EB, Awad IA.
    Toward more rational prediction of outcome in patients with high-grade subarachnoid hemorrhage.
    Neurosurgery. 2000 Jan;46(1):28-35; discussion 35-6.
  • Claus EB, Schildkraut J, Iversen ES, Berry D, Parmigiani G.
    Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history.
    J Natl Cancer Inst. 1998 Dec 2;90(23):1824-9.
  • Claus EB, Schildkraut JM, Thompson WD, Risch NJ.
    The genetic attributable risk of breast and ovarian cancer.
    Cancer. 1996 Jun 1;77(11):2318-24.
  • Claus EB, Schwartz PE.
    Familial ovarian cancer. Update and clinical applications.
    Cancer. 1995 Nov 15;76(10 Suppl):1998-2003.
  • Tinetti ME, Doucette JT, Claus EB.
    The contribution of predisposing and situational risk factors to serious fall injuries.
    J Am Geriatr Soc. 1995 Nov;43(11):1207-13.
  • Claus EB.
    The genetic epidemiology of cancer.
    Cancer Surv. 1995;25:13-26.
  • Tinetti ME, Baker DI, McAvay G, Claus EB, Garrett P, Gottschalk M, Koch ML, Trainor K, Horwitz RI.
    A multifactorial intervention to reduce the risk of falling among elderly people living in the community.
    N Engl J Med. 1994 Sep 29;331(13):821-7.
  • Claus EB, Risch N, Thompson WD.
    Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction.
    Cancer. 1994 Feb 1;73(3):643-51.
  • Claus EB, Risch N, Thompson WD.
    The calculation of breast cancer risk for women with a first degree family history of ovarian cancer.
    Breast Cancer Res Treat. 1993 Nov;28(2):115-20.